Pilot study on the efficacy and safty of low-dose tocilizumab therapy in elderly RA patients
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000008185
- Lead Sponsor
- Kyushu University Beppu Hospital Department of Metabolism, Hematology and Rheumatic Diseases (DMHRDs)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Pateints whose RA stage is Steinbroker IV. Patients who have ever been treated with tocilizumab. Patients who are given 10mg or more PSL daily within 4 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method